Skip to main content
Tech.euFundingExplorerBeta

LifeLink Ventures

Investor profile

Venture capital

LifeLink Ventures has backed 1 European tech company across 1 funding round in 2025, joining rounds totalling €58M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2025
1 yr
Total round €
€58M
sum of rounds joined

Deals by year

distinct rounds / year
LifeLink Ventures — deals by year — interactive chart.
Data table
LifeLink Ventures — deals by year
20251

Top sectors

by deals
LifeLink Ventures — top sectors — interactive chart.
Data table
LifeLink Ventures — top sectors
Healthtech1

Stages

by deals
LifeLink Ventures — stages — interactive chart.
Data table
LifeLink Ventures — stages
Series A1

Countries

by deals
LifeLink Ventures — countries — interactive chart.
Data table
LifeLink Ventures — countries
Switzerland1

Co-investment network

shared rounds
Co-investment network — interactive chart.
LifeLink Ventures — 1 dealsLifeLink Ventures+ND Capital — 1 shared deals · click to open+ND Capital4see Ventures — 1 shared deals · click to open4see VenturesAlexandria Venture Investments — 1 shared deals · click to openAlexandria Venture InvestmentsApollo Health Ventures — 1 shared deals · click to openApollo Health VenturesAthos Capital — 1 shared deals · click to openAthos CapitalBernina BioInvest — 1 shared deals · click to openBernina BioInvestEarlybird Venture Capital — 1 shared deals · click to openEarlybird Venture CapitalEli lilly and company — 1 shared deals · click to openEli lilly and companyLongview Ventures — 1 shared deals · click to openLongview VenturesSchroders Capital — 1 shared deals · click to openSchroders CapitalSofinnova Partners — 1 shared deals · click to openSofinnova Partners

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
haya therapeuticsSwitzerland1€58M

Biggest deals

top 10 by amount
CompanyStageAmountDate
haya therapeuticsSeries A€58M2025-05
← Back to investors